Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001231919-26-000604

Director acquired 35,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. Director 2026-06-03 Grant or award +35,500 48,300 I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2026-06-03 Grant or award · Stock Option (Right to Buy) +53,250 53,250 I
Loading xslF345X06/form4-06052026_090630.xml…